XtalPi logo

XtalPi

North America, Massachusetts, United States, Cambridge

Description

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Investor Profile

XtalPi has backed more than 15 startups, with 9 new investments in the last 12 months alone. The firm has led 6 rounds, about 40% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in China, United States, Switzerland.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Medical.
  • Led 6 rounds in the past year.

Stage Focus

  • Seed (40%)
  • Series A (27%)
  • Series Unknown (13%)
  • Series B (7%)
  • Angel (7%)
  • Corporate Round (7%)

Country Focus

  • China (47%)
  • United States (20%)
  • Switzerland (13%)
  • United Kingdom (7%)
  • Japan (7%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Biopharma
  • Health Care
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Medical Device
  • Alternative Medicine
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does XtalPi frequently co-invest with?

Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
FV
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Yael Capital Management Limited
Asia, Guangdong, China, Shenzhen
Co-Investments: 4
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 4
Fuho Capital
Asia, Beijing, China, Haidian
Co-Investments: 2
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 1
Tiantu Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does XtalPi often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by XtalPi?

Prenetics

Hong Kong, Hong Kong Island, Hong Kong

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

BiotechnologyGeneticsHealth CareHealth DiagnosticsPersonal HealthWellness
Post Ipo EquityOct 27, 2025
Amount Raised: $48,000,000
PrinMed

Beijing, Beijing, China

PrinMed is an innovative company focused on AI infrastructure resources and technology platforms.

Health Care
Corporate RoundSep 12, 2025
Foundry BioSciences

Boston, Massachusetts, United States

Foundry Bio is a generative AI protein design platform.

BiotechnologyHealth CareLife SciencePharmaceutical
Pre SeedJul 2, 2025
Xellar Biosystems

Newton, Massachusetts, United States

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
SeedApr 28, 2025
Newdel Biotech

Shenzhen, Guangdong, China

Newdel Biotech offers drug screening services along with biomedical technology development and consulting.

BiopharmaBiotechnologyHealth CareMedical
Series AMar 12, 2025
FuChe Biotech

Berkeley, California, United States

FuChe Biotech is a biotechnology startup which Empower a clear future and innovative technology.

BiotechnologyMedicalSustainability
SeedFeb 27, 2025
META Pharmaceuticals

Shenzhen, Guangdong, China

META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.

MedicalPharmaceutical
Series UnknownFeb 17, 2025
Merda Biopharma

Futian, Guangdong, China

Merda Biopharma is a AI-enabled drug discovery technology platform that produces small molecule drugs that helps immune metabolism.

BiopharmaBiotechnology
Series AFeb 14, 2025
Alternative Bio

China, Kagoshima, Japan

Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.

BiotechnologyTherapeutics
Corporate RoundFeb 10, 2025

Orient Biotech is a private biotechnology company developing innovative drugs for underappreciated modified processing enzymes.

BiopharmaBiotechnologyHealth Care
Series UnknownFeb 10, 2025